Interventional Psychiatry Program at St. Michael’s Hospital, Unity Health Toronto is a clinical and academic centre that aims to define best treatment and care for people with depression, suicidal behaviour and related challenges through innovative research and knowledge translation. The centre facilitates the efficiency and growth of novel treatment options for Mood and other Disorders, with the focus on psychopharmacological (e.g., IV ketamine/other anesthetic agents), neurostimulation (e.g., ECT, rTMS, emerging neurostimulation modalities), and digital therapeutic (e.g., mobile-based monitoring and interventions) interventions. Our Program collaborates closely with anesthesia, imaging, informatics, neurology and neurosurgery, and aims to identify and understand risks and treatment response with these emerging procedures. By integrating research with education and knowledge translation, we strive to create a stronger investment in mental healthcare and ultimately improve health policy and clinical practice.
Interventional Psychiatry Program is home to the Arthur Sommer Rotenberg (ASR) Suicide & Depression Studies Program at St. Michael’s Hospital and the University of Toronto (www.asrlife.ca). It is also the coordinating centre for the Canadian Biomarker Integration Network in Depression (CAN-BIND, www.canbind.ca), sponsored by the Ontario Brain Institute (OBI) with additional support from the Ontario Research Fund (ORF), the Canadian Institutes for Health Research (CIHR) and other granting agencies, charitable organizations and industry partners. The Centre has a network of over 60 researchers and clinicians across five provinces in Canada, including: British Columbia, Alberta, Ontario, Quebec and Nova Scotia.